Showing results (191-200 of 703) with videos related to

Sort By:
Pageof 71
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Visual rating of white matter hyperintensities in Parkinson's diseaseMona K Beyer, Dag Aarsland, Ole Jacob Greve, et al.
Kidney International Reports|June 9, 2025
The Utility of Myeloperoxidase Immunostaining to Characterize Immune Deposits in Patients With Crescentic GlomerulonephritisRachelle Gietzen, Tiffany N Caza, Alejandro Best-Rocha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 18, 2014
Thrombotic microangiopathy and acute kidney injury associated with intravenous abuse of an oral extended-release formulation of oxymorphone hydrochloride: kidney biopsy findings and report of 3 casesJosephine M Ambruzs, Paul B Serrell, Naeem Rahim, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 25, 2014
Influence of shear on nitrification rates in a membrane bioreactorM A Lou, P Larsen, P H Nielsen, et al.
Ophthalmology Science|February 5, 2025
Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping ReviewPetra P Larsen, Virginie Dinet, Cécile Delcourt, et al.
Canadian Journal of Physiology and Pharmacology|December 20, 2002
Calcium-stimulated short-circuit currents in the canine proximal colonic epithelium: effects of DK-PGD2, a metabolite of prostaglandin D2P Larsen, E Schleihauf, H Yu, et al.
Kidney International|February 26, 2010
Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsiesChristopher P Larsen, Patrick D Walker, Deborah T Weiss, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1996
Patient characteristics, MRI examination, and dopaminergic drug response in clinical possible Parkinson's diseaseJ P Larsen, H Odegaard, E Tandberg, et al.
Pageof 71